Why Alkermes spun out an oncology company, whose shares have plummeted - Boston Business Journal

Published on 17 Nov 2023 on The Business Journals

A year after it first floated the idea, Alkermes plc has broken out its cancer unit into a separate...

Read the rest of the article

Start tracking your investments with Statfolio

A year after it first floated the idea, Alkermes plc has broken out its cancer unit into a separa...

The Business Journals 17 Nov 2023

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Investing.com 17 Nov 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 100 poi...

Benzinga 16 Nov 2023

A three-year-old biotech backed by the venture arms of Sanofi ADR and Bristol Myers Squibb is goi...

The Business Journals 16 Nov 2023

In this piece, we will take a look at the 12 best nano cap stocks to buy now. If you want to skip...

Insider Monkey via Yahoo Finance 6 Jul 2023

SolGel Technologies Ltd. (SLGL) came out with a quarterly loss of $0.15 per share versus the Zack...

Zacks via Yahoo Finance 26 Mar 2023

As an investor, mistakes are inevitable. But really big losses can really drag down an overall po...

Simply Wall St. via Yahoo Finance 24 Feb 2023

Homology Medicines Inc (NASDAQ: FIXX) expects to provide initial data from the pheEDIT trial of H...

Benzinga via Yahoo Finance 5 Jan 2023

Homology Medicines (FIXX) came out with a quarterly loss of $0.59 per share versus the Zacks Cons...

Zacks via Yahoo Finance 10 Nov 2022

Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care...

American City Business Journals 8 Sep 2022